In order to give effect to the decisions of the Board of Directors of Egypt Healthcare Authority,
Egypt Healthcare Authority establishes the Drug and Pharmacological Assessment Unit in health facilities in the departments of comprehensive health insurance
Egypt Healthcare Authority: The Drug Use Assessment and Pharmacologically Appropriate Unit aims to improve the quality of care and the effectiveness of medication and to reduce drug abuse and abuse
Egypt Healthcare Authority: Assessing the use of medicines is an essential foundation for the implementation of pharmaceutical quality management programs, ensuring that the patient has the highest therapeutic effectiveness and the lowest side effects, and maintaining the quality of life of the patient
Egypt Healthcare Authority: Evaluation of drug use is a comprehensive and periodic process of review, evaluation and intervention for corrective action to promote optimal, safe and effective use of medicines
Egypt Healthcare Authority has announced the establishment of a unit to evaluate the use of medicines and medicines in order to improve the quality of care and the effectiveness of medicines in general and to reduce the abuse and abuse of medicines, in implementation of the resolutions of the Board of Directors of the Authority, chaired by Dr. Ahmed El-Sobky, Chairman of the Board of Directors of the Authority, Assistant Minister of Health and Population and General Supervisor of the Universal Health Insurance Project, at the first meeting of the Board at its second and periodic session, in the framework of coordination and complementarity with the vital role played by the Egyptian Medicine Authority.
Dr. Sharif Kamal, Adviser to Egypt Healthcare Authority for Pharmacological and Drug Administration and Director of the Medicine and Pharmacological Administration of the Authority, stated that the Unit for the Evaluation of the Use of Pharmacologically Appropriate Medicines was aimed at improving the quality of care and the overall effectiveness of medicines at the health facilities of the Authority in the departments of comprehensive health insurance, preventing back-to-back drug reactions, encouraging the practice of clinically appropriate and effective medicines, reducing the abuse and abuse of medicines and reducing costs related to inappropriate drug use.
He explained that the drug use assessment program was an essential part of the health team, with the participation of a doctor in developing the treatment plan and following up on its implementation with the patient or nursing team, which reviewed the doctor's prescription to ensure that the patient was fit in terms of "use reasons, dose, frequency of dose, method of giving," and then prepared treatment in a patient-friendly form, and also trained nursing to give treatment, following that it included the pharmaceutical follow-up program to evaluate the use of medicines which operated at various levels of the individual patient, group of patients or the level of exchange and inventory.
The Drug Use Assessment Program was an approved, regulated and continuous system for improving the quality of the use of medicines in health facilities, noting that the use of medicines was assessed using a set of predefined criteria, while efforts were made to correct patterns of use that did not conform to those standards, and it also included a mechanism to measure the effectiveness of corrective action to promote the optimal, appropriate, safe and effective use of medicines.
The assessment of the use of medicines was a comprehensive and dynamic process of review, evaluation and intervention, and included two basic phases, the first "survey," which included the measurement and definition of drug use, the identification of drug abuse problems, the measurement of the impact of interventions, and the second "intrusive" phase, in which problems were solved, the building of scientific consensus on indicative evidence, and the implementation of remedial activities and actions to improve drug use and efficacy.
Dr. Sharif Kamal emphasized that the system for evaluating the use of medicines was a fundamental foundation for the delivery of pharmaceutical service, clinical exercise and quality assurance and management programs, ensuring that the patient had the highest therapeutic effectiveness and the lowest side effects and maintaining the quality of life of the patient, noting that the focus would be on antibiotics, since the optimal use of medicines began with the optimal use of antibiotics, and noting that WHO had identified the role of the pharmacist in three areas, the most important of which was improving the health of society, preventing the disease and then treating the disease.
